Established 1999
     
8,000 companies from USA and India.  
   
Search over 34,500 News & Earnings Database    
 
Earnings Calls: 
Johnson and Johnson Earnings Call, Fourth Quarter 2008
Author: Maclintosh Kuhlengisa
123jump.com
Last Update: 6:21 PM ET January 21 2009
123Jump:


(Continued)

Email article | Print article

The pharmaceutical firm realized a 5% dip in sales to $15 billion due to negative currency impact. Lower cost of goods drove a 14% rise in income to $2.7 billion or 97 cents a share as it continues to make progress in the research pipelines while investing in the future growth of the business.

Investors Question and Answers

 
 Company Website Links:
Investor Relations Financial Info Corporate / History Profile Executives Products Services
 
Sequential Earnings Growth | Quarterly Earnings by Year | Quarterly Earnings Growth by Year
You need to upgrade your Flash Player


You need to upgrade your Flash Player

 
Dominic Caruso: The Remicade issue was in the several hundred million dollar range of sales that due to scheduling issues in the production plan due to maintenance in the plan was simply deferred due to the timing of completing those events and it had nothing to do with any credit issues or any other issues with respect to the product.
  1  2  3  4 More: Earnings Calls

 
 
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites.
Market data: BATS Exchange. Inc.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
Other Sites:
© 1999-2010 123jump.com. All rights reserved